KRAS and colorectal carcinoma: In this review, it is described which new therapies have been developed in order to target KRAS-induced cell death resistance, expecting to bring new avenues to the discovery of novel therapeutic approaches for CRC, based on the involvement of KRAS mutations in apoptosis and autophagy regulation.